The 2026 Best Law Firms in the United States list has been announced, and it includes Weitz & Luxenberg. This independent peer-to-peer, industry-driven evaluation recognizes exceptional firms nationwide. Our firm believes it is truly an honor to receive such a distinction year after year. Best Law Firms annual rankings are marking their 16th year. Since…

Weitz & Luxenberg is pursuing cases of significant liver injury in people who took Ocaliva (obeticholic acid) to treat primary biliary cholangitis (PBC), an autoimmune condition that causes gradual destruction of the bile ducts in the liver. Following a request from the U.S. Food and Drug Administration (FDA), the manufacturer Intercept Pharmaceuticals withdrew Ocaliva from…

Super Lawyers, a respected national attorney rating service, has released its 2025 list of top attorneys for the New York Metro Area. Weitz & Luxenberg proudly announces that a number of our attorneys have been named to this list as either Super Lawyers or Rising Stars. Over the last nearly 40 years, Weitz & Luxenberg…

Weitz & Luxenberg is taking legal cases for patients who have cutaneous T-cell lymphoma (CTCL) and used an anti-inflammatory medication. Reach out to us if you have been diagnosed with this type of skin cancer, so we can help you get the financial compensation you deserve. Dupixent (dupilumab) is prescribed to patients diagnosed with moderate…

Weitz & Luxenberg is expanding our litigation involving type 2 diabetes drugs leading to blindness to include Victoza and Saxenda liraglutide. Our ongoing litigation focuses on the dangers of semaglutides. Our expanded litigation now includes the dangers of liraglutides.  Both semaglutides and liraglutides are intended to treat type 2 diabetes. According to studies, both can…

The Truth About Grand Design RVs & Frame Failures During the COVID pandemic, Grand Design took advantage of consumers. The company decided it could make a lot of money selling RVs to people looking to avoid crowds, travel the country, and start a new life. The demand for this new life grew. Due to labor…

Weitz & Luxenberg is delighted to announce Ellen Relkin is being inducted into the Trial Lawyer Hall of Fame in April. Ms. Relkin is a partner in W&L and chair of our firm’s Drug and Medical Device Litigation group. She is being honored in a ceremony at the Mass Torts Made Perfect (MTMP) conference, held…

UPDATE 11/12/2025: The petition filed by Weitz & Luxenberg to the Administrative Office of the Courts of the State of New Jersey seeking a multicounty litigation (MCL) for NAION Ozempic/Wegovy was granted. These cases will now be transferred to Bergen County and consolidated before Judge Padavano in the state for coordinated proceedings. W&L has filed 16 lawsuits against…

Weitz & Luxenberg is pursuing legal cases on behalf of people taking Oxbryta (voxelotor) to treat sickle cell anemia. Potential clients may be people suffering from an increase in vaso-occlusion crisis events or the death of a loved one. These are the main Oxbryta side effects leading to its recall. If you used Oxbryta and…

Weitz & Luxenberg is investigating cases of severe liver damage in women who took Veozah to treat menopausal hot flashes. The U.S. Food and Drug Administration (FDA) warns that using Veozah (fezolinetant), “can cause rare but serious liver injury.” If you used Veozah to treat menopausal hot flashes and developed a severe liver injury, reach…